Close Alert Banner
Skip to Content

Hospital

ResearchFoundation

Text Resize

Regular Large X-Large

Colour Contrast

Default High

Accessible formats and communication supports are available, please contact accessibility@cheo.on.ca

View Our Accessibility Plan

CareersContact UsWebsite FeedbackMyChart
FR
Childrens Hospital of Eastern Ontario Logo
Contact Us
  • Coming to CHEO
    • Accessibility
    • Amenities
    • CHEO KidCare Pharmacy
    • Health Records
    • Maps and locations
    • Parking
    • Patient safety
    • Pay your bill
    • Preparing for your stay or visit
    • Research Connection
    • Visiting hours and policies
    View our Physician directory page
    Find Your Doctor Directory
  • Clinics, Services & Programs
    • A-Z Directory
    • Core Innovation
    • Emergency care
    • IR/Cath and Sim Labs
    • Make a referral
    • Mental health
    • School
    • Surgical care
    • Virtual care
  • Resources and Support
    • A-Z resources
    • Community supports
    • Families First newsletter
    • Family and caregiver supports
    • Indigeneity - Inclusion, Diversity, Equity, Accessibility, Social justice
    • Patient Experience
    • Transition to adult care
  • Get Involved
    • Co-op program
    • Donate
    • Family Advisory Council
    • Feedback
    • Share your voice
    • Volunteer
    • YouthNet
  • About Us
    • About CHEO
    • Careers at CHEO
    • CHEO leadership
    • For community physicians
    • For learners, students and residents
    • For pharmacists
    • Newsroom
    • Our partners
    • Privacy and confidentiality

Cutting-edge CHEO research finds 'rare amongst rare’

doctor kim boycott stands in lab with arms crossed

Regular Large X-Large
 
  • Open new window to share this page via Facebook Facebook
  • Open new window to share this page via LinkedIn LinkedIn
  • Open new window to share this page via Twitter Twitter
  • Email this page Email
Subscribe to Blog

Contact us

Receive Email Updates...
Email icon Back to Search
cheo doctor stands in lab with arms crossed

For the Osborne family, it took over a decade to complete the puzzle of Austin Osborne’s condition. 

Austin was first seen by the genetics team at CHEO in 2007, and was suspected to have Joubert syndrome, but genetic testing at the time was negative for mutations in the genes known to cause this rare brain malformation syndrome. In 2013, his younger brother Parker unfortunately died of what was believed to be the same condition.  boy smiles while sitting in a wheelchair holding a trophy

“When we lost Parker, we wanted his death to make a difference for other families going through the same thing as us, so we made sure we could donate samples from him for research purposes. This opened new opportunities for finding answers,” said Lincoln, Austin’s dad.  

And it did. Every year, researchers at CHEO learn more about genes that cause rare diseases and implement new cutting-edge genomic technologies that make new diagnoses possible.  

In 2019, Care4Rare, a team focused on improving the diagnostic care of rare genetic disease patients in Canada and around the world, re-analyzed the exome sequencing data from Austin and Parker and found both had a rare mutation in one copy of a gene recently discovered to cause Joubert syndrome (the CEP120 gene). By 2022, Care4Rare performed cutting-edge tests to look for the second mutation and identified a hard-to-detect mutation in the other copy of the CEP120 gene. This confirmed the diagnosis of Joubert syndrome, providing the Osborne family with a long-awaited answer to help care for Austin and advocate for his needs.  

“It was a relief when we finally got this piece of the puzzle,” added Lincoln. “Austin represents less than 3 per cent of all Joubert syndrome cases. He’s rare amongst rare and we are forever grateful to Dr. Kym Boycott and the team at CHEO and Care4Rare. We always felt that no matter what challenges we faced, we always had to try and find answers not only for Austin, but for as many families living with a rare disease."  

rare disease day flag raised at ottawa city hall with blue sky in backgroundCHEO is internationally known as a leader in rare disease research, genetic testing, and clinical care 

Dr. Kym Boycott, Clinical Geneticist and Senior Scientist at CHEO, leads Care4Rare, which is based out of the CHEO Research Institute, and is an internationally renowned expert in rare disease research, the implementation of new genetic technologies, and the coordination of data to end the diagnostic odyssey for rare disease patients. 

On Thursday, Dr. Boycott was part of the launch of the Canadian Rare Disease Network (CRDN) at the Canadian Organization for Rare Disorders (CORD) Summit in Ottawa.  

The CRDN’s research-to-care model integrates research, translation, and patient-centered care to break new ground in addressing the complex challenges faced by people with rare diseases in Canada.  

Learn more about the CRDN here.  

The All for One Precision Health Partnership between CHEO and SickKids was also announced today as part of Rare Disease Day. This first-of-its-kind national program will enable secure data sharing between Canadian rare disease diagnostic laboratories. Osborne family stands at rare disease day flag raising  

“Individually, no single institution or health region can sequence enough people’s DNA to build a comprehensive database to support high-quality interpretation of clinical genome-wide sequencing. This is particularly true for equity-deserving populations who are also underrepresented in current genomic reference datasets. The All for One Precision Health Partnership is changing that and providing a blueprint for other countries around the world,” said Dr. Boycott, who is the All for One data sharing lead. 

The diagnostic laboratories at CHEO and SickKids are pioneering the sharing of genome-wide sequencing data by contributing data from over 4,000 rare disease patients and family members. This secure data sharing will increase health care providers’ ability to provide answers to families and may decrease their anxious wait for a diagnosis. As this gets built out across Canada, it means that when a rare disease family receives genome-wide sequencing in one province, their test information may very well help to diagnose a family in another.    

Learn more about All for One here.

Researchers, clinicians and bioinformaticians at CHEO are at the leading-edge of discoveries and new technologies to help patients and families with rare disease. 

To support this work, you can donate through the CHEO Foundation.

0 Likes

Comments

Login to Post a Comment

x
Login with Google Login with Facebook

No login? Please enter your details below to continue.

Receive Email Updates...

CHEO

  • Coming to CHEO
  • Clinics, Services & Programs
  • Resources and Support
  • Get Involved
  • About Us

Contact Us

CHEO
401 Smyth Road
Ottawa ON K1H 8L1
Phone: 613-737-7600
Email Us

 

Connect with us

View our Facebook Page View our Instagram Page View our YouTube Page View our LinkedIn Page

Sign up for our newsletter

twitter:00000000-0000-0000-0000-000000000000

Children's Hospital of Eastern Ontario logo

Copyright 2025 CHEO.

By GHD Digital
  • Sitemap
  • Accessibility
  • Disclaimer
  • Privacy and confidentiality
  • Website Feedback
  • Contact Us

Staff Portal

Close Old Browser Notification
Browser Compatibility Notification
It appears you are trying to access this site using an outdated browser. As a result, parts of the site may not function properly for you. We recommend updating your browser to its most recent version at your earliest convenience.